We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
News in brief.
- Abstract
The article offers news briefs related to biotechnology as of November 2011. A National Venture Capital Association (NVCA) survey shows that more venture capitalists prefers to invest in European biotech companies than those in the U.S. A detailed review by "The Lancet Oncology" commission shows that policy reforms are needed to lessen cancer treatment costs. The U.S. National Institutes of Health (NIH) will release regulations on clinical trial results reporting requirements by the end of 2011.
- Subjects
BIOTECHNOLOGY; NATIONAL Venture Capital Association; VENTURE capital; LANCET Oncology, The (Periodical); CANCER treatment; NATIONAL Institutes of Health (U.S.); CLINICAL trials; ECONOMICS
- Publication
Nature Reviews Drug Discovery, 2011, Vol 10, Issue 11, p801
- ISSN
1474-1776
- Publication type
Article
- DOI
10.1038/nrd3582